Satellite Symposia
The Satellite Symposia are industry-sponsored, CME-certified programs offered in conjunction with ASH specialty meetings. These events are offered in conjunction with the 2023 Meeting on Hematologic Malignancies (MHM) and are not part of the official ASH meeting programming and are planned solely by the sponsoring company. There is no fee to attend and registration to MHM is not required to participate.
The 2023 Satellite Symposia are each presented once, live at the date, time, and location listed. To register, click the “Register” button below. Check back as registration links and details will continue to be added as managing companies share them with ASH. For program-specific questions, please reach out to the managing company contact listed below each session.
ASH appreciates its corporate and nonprofit partners for their participation in Satellite Symposia. The Society values its partnerships and the supportive role that members of this community play to provide hematologists with quality educations programs. The deadline for applications has passed. For more information, please review the Satellite Symposia Guidelines.
Bruton Tyrosine Kinase Inhibitors in CLL: Case Challenges and Clinical Insights
Friday, September 8, 2023, at 6:00 – 8:00 p.m. CT
Fairmont Chicago, Millennium Park, Chicago, IL in the Gold Room
This symposium is CME-certified and will be presented LIVE at the date, time, and location above. This program is supported by AstraZeneca, Beigene & Janssen/Pharmacyclics.
The live/livestreamed (livestream by MedscapeLIVE) symposium will combine the real-life engagement of live instruction provided by key opinion leaders with the reach, impact, and convenience of virtual and enduring online education. The overall goal of this education will be for learners to be better able to integrate the latest data on BTK inhibitors into clinical practice, appropriately select and sequence therapies for CLL, and optimally manage treatment-related adverse events across the treatment continuum.
Managing Company: MedscapeLIVE
Symposium Contact: Pavan Nandi at [email protected]
How We Do It®: Novel Biologic Strategies Reshaping Treatment Decision-Making in Pediatric to Adult Hodgkin Lymphoma
Friday, September 8, 2023, at 6:00 – 8:00 p.m. CT
Fairmont Chicago, Millennium Park, Chicago, IL in the State Room
This symposium is CME-certified and will be presented LIVE at the date, time, and location above.
The live portion of this curriculum will be presented as a live 2-hour Friday Satellite Symposium (FSS) held prior to the ASH Annual Meeting. The live activity will feature a series of didactic presentations coupled with Medical Crossfire® from prominent experts in the field that will be used as a starting point to discuss the latest data across forms of HL. The activity is designed to highlight and test participants on the most clinically relevant data in HL, provide expert guidance on the interpretation of core concepts, and forecast the clinical impact of recent data sets.
The activity will integrate a series of How We Do It® panel discussions alongside didactic presentations. These panel discussions are intended to illuminate “Real World” use of clinical trial data and practical considerations.
To further enhance the integration of recent data into practice, the program will feature an interactive question-and-answer session with faculty throughout the activity to emphasize areas of educational need, highlighting areas of debate, and illustrating the application of new data in defined clinical situations.
Clinical practice pattern questions will be integrated throughout for interactivity. Results will be included in the final outcomes report.
Managing Company: Physicians’ Education Resource, LLC
Symposium Contact: Kirby Beneville at [email protected].
Questions?
Please contact Kelly Cade, ASH Grants and Satellite Symposia Manager, Consultant, at [email protected].